Forus Hits $3B Valuation While FDA Still Writes AI Rules
The money is moving faster than the regulations, and that's exactly the point. Forus raised $150M at a $3B valuation in a Series C led by Bain Capital Ventures, with repeat backing from Accel, Thrive, General Catalyst, and others
Continue reading ›